Institutional Ownership Oramed Pharmaceuticals Inc. (ORMP)
This table provides information about the institutional ownership of Oramed Pharmaceuticals Inc. (ORMP). We have compiled data on the 62 institutions that hold shares in the stock, with a total of 8.22 Million shares, which have been reported (via 13F filing form) to have a value of $17.4 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Tower Research Capital LLC (Trc)
New York, NY |
May 15, 2025 Q1 2025 |
649
shares
|
$1,375
0.0% of portfolio
|
Q1 2025
Reduced 75.46%
|
|
|
Jones Financial Companies Lllp
|
May 28, 2025 Q1 2025 |
500
shares
|
$1,060
0.0% of portfolio
|
Q1 2025
Reduced 66.67%
|
|
|
Ifp Advisors, Inc
|
May 05, 2025 Q1 2025 |
500
shares
|
$1,060
0.0% of portfolio
|
Q1 2024
Reduced 66.67%
|
|
|
Covington Capital Management
|
Nov 14, 2022 Q3 2022 |
325
shares
|
$689
0.0% of portfolio
|
Q3 2021
New holding
|
|
|
Golden State Wealth Management, LLC
Santa Ana, CA |
Apr 24, 2025 Q1 2025 |
303
shares
|
$642
0.0% of portfolio
|
Q1 2025
Reduced 50.0%
|
|
|
Beacon Capital Management, LLC
|
Jul 17, 2025 Q2 2025 |
219
shares
|
$464
0.0% of portfolio
|
Q4 2022
New holding
|
|
|
Hopwood Financial Services, Inc.
Reston, VA |
May 08, 2025 Q1 2025 |
200
shares
|
$424
0.0% of portfolio
|
Q4 2024
New holding
|
|
|
Time Scale Financial, Inc.
|
Jul 26, 2023 Q2 2023 |
125
shares
|
$265
0.0% of portfolio
|
Q3 2020
Added 48.81%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
May 15, 2025 Q1 2025 |
33
shares
|
$69
0.0% of portfolio
|
Q1 2025
Reduced 99.95%
|
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
May 14, 2025 Q1 2025 |
0
shares
|
$0
100.0% of portfolio
|
Q1 2025
Closed
|